LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Reset all filters
01 1LGM Pharma
02 1HRV Global Life Sciences
03 1Lee Pharma
04 1Acura Labs
05 1Apicore
06 1Arene Lifesciences
07 1Aspire Lifesciences Pvt Ltd
08 1Aurobindo Pharma Limited
09 1Aurore Life Sciences
10 1Chromo Laboratories
11 1Corey Organics
12 2Divis Laboratories
13 1Emcure Pharmaceuticals
14 3Hetero Drugs
15 2Laurus Labs
16 2Lupin Ltd
17 1Lupin Manufacturing Solutions
18 1MSN Laboratories
19 1Maithri Drugs
20 1Mana Pharma SL
21 1Merck & Co
22 1Prajna Generics
23 1SGMR Pharmaceuticals
24 1Saintsun Pharma
25 1Shanghai Desano Chemical Pharmaceutical Co., Ltd.
26 1Shenzhen Oriental Pharmaceutical
27 1Siegfried AG
28 1Teva Pharmaceutical Industries
29 1Tianish Laboratories
30 2Viatris
31 1Viwit Pharmaceuticals Limited
Reset all filters
01 4China
02 26India
03 1Israel
04 1Spain
05 1Switzerland
06 4U.S.A
Reset all filters
01 7Active
02 2Inactive
03 28Blank
01 3Valid
02 34Blank
Reset all filters
01 37Blank
Reset all filters
01 1WC-0030n
02 1WC-0040n
03 1WC-0118
04 1WC-0213
05 1WC-0407
06 1WC-0436
07 1WC-0459
08 1WC-0487
09 29Blank
Reset all filters
01 1906-5-ND
02 1No. 906-10-ND
03 1Su90-20-ND
04 1Su90-21-ND
05 33Blank
Reset all filters
01 117381-749
02 159651-924
03 162331-055
04 165015-841
05 165977-0049
06 165977-0129
07 165977-0158
08 170600-028
09 29Blank
01 37Blank
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Lee Pharma Ltd: Global supplier of certified APIs and formulations, driven by innovation and regulatory excellence.
GDUFA
DMF Review : Reviewed
Rev. Date : 2022-09-15
Pay. Date : 2022-08-25
DMF Number : 34206
Submission : 2019-09-30
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2024-02-14
Pay. Date : 2023-12-22
DMF Number : 39315
Submission : 2023-12-30
Status : Active
Type : II
NDC Package Code : 59651-924
Start Marketing Date : 2023-12-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-03-31
Pay. Date : 2013-12-09
DMF Number : 27728
Submission : 2013-12-24
Status : Active
Type : II
Date of Issue : 2022-07-06
Valid Till : 2025-08-04
Written Confirmation Number : WC-0118
Address of the Firm :
NDC Package Code : 65015-841
Start Marketing Date : 2015-01-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2016-09-02
Pay. Date : 2016-06-21
DMF Number : 30595
Submission : 2016-06-24
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25753
Submission : 2012-04-02
Status : Inactive
Type : II
Date of Issue : 2025-02-20
Valid Till : 2028-01-28
Written Confirmation Number : WC-0436
Address of the Firm :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26935
Submission : 2013-03-28
Status : Inactive
Type : II
Certificate Number : CEP 2023-329 - Rev 00
Issue Date : 2024-12-02
Type : Chemical
Substance Number : 2887
Status : Valid
10
PharmaCompass offers a list of Raltegravir Potassium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Raltegravir Potassium manufacturer or Raltegravir Potassium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Raltegravir Potassium manufacturer or Raltegravir Potassium supplier.
PharmaCompass also assists you with knowing the Raltegravir Potassium API Price utilized in the formulation of products. Raltegravir Potassium API Price is not always fixed or binding as the Raltegravir Potassium Price is obtained through a variety of data sources. The Raltegravir Potassium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Raltegravir Potassium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Raltegravir Potassium, including repackagers and relabelers. The FDA regulates Raltegravir Potassium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Raltegravir Potassium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Raltegravir Potassium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Raltegravir Potassium supplier is an individual or a company that provides Raltegravir Potassium active pharmaceutical ingredient (API) or Raltegravir Potassium finished formulations upon request. The Raltegravir Potassium suppliers may include Raltegravir Potassium API manufacturers, exporters, distributors and traders.
click here to find a list of Raltegravir Potassium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
We have 31 companies offering Raltegravir Potassium
Get in contact with the supplier of your choice: